期刊文献+

两种不同的尿激酶溶栓方法对中心静脉永久性导管内血栓的疗效研究

Study of the Effects of Two Different Thrombolytic Methods Treated with the Thrombus in the Permanent Central Venous Catheters by Urokinase
下载PDF
导出
摘要 目的:比较使用尿激酶持续泵入法与美国肾脏病基金会肾脏病预后质量倡议(Kidney disease outcomes quality initia-tive,K/DOQI)指南推荐的方法对中心静脉永久性导管血栓的治疗效果。方法:对66例临床诊断导管内血栓形成病例进行随机对照临床研究,其中治疗组33例,对照组33例,治疗组使用1000单位/ml尿激酶溶液100ml以50ml/小时持续泵入;对照组采用5000单位/ml尿激酶溶液2ml进行溶栓治疗,比较两种溶栓方法对中心静脉永久导管血栓的治疗效果及副作用。结果:治疗组溶栓后通畅率93.9%,对照组溶栓后通畅率90.9%,两组溶栓后通畅率差异无统计学意义。溶栓成功半月后,治疗组通畅率84.8%,对照组通畅率60.6%,溶栓成功一月后,治疗组通畅率81.8%,对照组通畅率54.5%,两组患者再次形成血栓的比例差异有统计学意义。两种不同溶栓治疗方案对患者凝血功能无明显影响。结论:尿激酶持续泵入法与常规溶栓法比较,其治疗成功率高,复发率低,无明显副作用及治疗并发症。 Objectives. To compare with the treatment effects of two thrombolytic methods treated with the thrombus in the permanent central venous catheters by urokinase, which one is continouse-pumping tech- nique,and the other is recommend by the K/DOQI guidelines of American Kidney Disease Foundation. Meth- ods. Sixty-six cases clinically diagnosed with thrombosis in catheters were involved in this randomized con- trolled clinical study. Thirty-three cases were involved in the treatment group, and the other 33 cases were in- volved in the control group. The treatment group apply with a technique of continouse-pumping with a 100 ml urokinase solution in a concentrention of 1000u/ml, and the control group treated with the thrombus with a 2 ml urokinase solution in a concentrention of 5000u/ml. Compare with the treatment effects and side effects of the two thrombolytic methods treated with the thrombus in the permanent central venous catheters. Results. The perforation rates of post-thrombosis of the treatment group is 93. 9%, and the control group is 90. 9%, the difference of the two groups has no statistic significance. After half a month, the treatment group is 84. 8%, and the control group is 60. 6%, while after a month, the treatment group is 69. 7%, and the control group is 42. 4%, the proportions of re-thrombosis have a significant statistic difference. The two different thrombolytic methods have no significant effects on the patient's coagulations. Conclusions. Compared with the conventional thrombolytic method, the continouse-pumping technique have high cure rates and low re- lapse rates,with no significant side effects and complications.
出处 《数理医药学杂志》 2013年第3期314-316,共3页 Journal of Mathematical Medicine
关键词 中心静脉永久性导管 血栓 尿激酶 溶栓 血液透析 central venous catheters thrombus urokinase thrombolysis Hemodialysis
  • 相关文献

参考文献9

  • 1Tanriover B , Carlton D, Saddekni S, et al. Bacteremia associated with tunneled dialysis catheters : Comparison of two treatment strategies. Kidney Int ,2000 ,57:2151-2155.
  • 2丁惠芳,黄海珍,胡棣.血液透析患者长期与暂时双腔留置导管的应用[J].透析与人工器官,2003,14(1):23-25. 被引量:8
  • 3Cynamon I ,Pierpont CE. Thromobolysis for the treatment of the thromobosed hemodialysis access grafts. Rev Cardiovasc Med , 2002 ,2:84-91.
  • 4美国NKF-K/DOKI工作组.慢性肾脏病及透析的临床实践指南.王海燕,王梅,译.北京:人民卫生出版社,2003,469.
  • 5Dupont D, Moriniere P, Pourehez T, et al. Long-term development of permach quinton catheters used as a vascular access route for ex- trarenal detoxication. Nephrology, 1994,15 : 105-110.
  • 6Cynamon J, Pierpont CE. Thrombolysis for the treatment of thrombosed hemo dialysis access grafts. Rev Cardiovasc Med, 2002, 3( Suppl 2) : 75-82.
  • 7戎殳,叶朝阳,张斌,陈静,梅长林.尿激酶在血液透析患者动静脉内瘘血栓形成治疗中的应用[J].中国综合临床,2005,21(4):322-324. 被引量:19
  • 8Cynamon J, Lakritz PS, Wahl SL, et al. Hemodialysis graft declotting: description of the % lyse and wait& technique. JVIR, 1997, 8(5) : 825-829.
  • 9张浩东.长期性双腔导管在血液透析中的应用[J].中国中西医结合肾病杂志,2005,6(1):45-46. 被引量:13

二级参考文献17

  • 1Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int, 2002,62(2) :620 - 626.
  • 2No authors Listed. Cause of death. USRDS. United States Renal Data System. Am J Kidney Dis, 1997,30(2 Suppl 1 ) :107- 117.
  • 3Di Iorio BR. Cuffed tunneled catheter as permanent hemodialysis access in lucania. AM J Kidney Dis, 2001,37(6) : 1333 - 1334.
  • 4Dupont D, Moriniere P, Pourchez T, et al. Long- term development of Permacath Quinton catheters used as a vascular access route for extra - renal detoxification. Nephrologie,1994,15(2) :105- 110.
  • 5Turmel-Rodrigues L,Sapoval M,Pengloan J,et al.Manual thromboaspiration and dilation of thrombosed dialysis access:mid-term results of a simple concept[J].JVIR,1997,8(5):813-824.
  • 6Cynamon J,Pierpont CE.Thrombolysis for the treatment of thrombosed hemodialysis access grafts[J].Rev Cardiovasc Med,2002,3(Suppl 2):75-82.
  • 7Cynamon J,Lakritz PS,Wahl SI,et al.Hemodialysis graft declotting:description of the"lyse and wait"technique[J].JVIR,1997,8(5):825-829.
  • 8Schon D,Mishler R.Salvage of occluded autologous arteriovenous fistulae[J].Am J Kidney Dis,2000,36(4):804-810.
  • 9Gruber A,Harker LA,Hanson SR,et al.Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates[J].Circulation,1991,84(6):2 454-2 462.
  • 10Sofocleous CT,Cooper SG,Schur I,et al.Retrospective comparison of the amplatz thrombectomy device with modified pulse-spray pharmacomechanical thrombolysis in the treatment of thrombosed hemodialysis access grafts[J].Radiology,1999,213(2):561-567.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部